BIOCON Plunges by 5%; BSE HEALTHCARE Index Down 0.5%
May 2, 2019 02 pm

BIOCON share price has plunged 5% and is presently trading at Rs 595.

Meanwhile, the BSE HEALTHCARE Index is at 14,413 (down 0.5%).

Among the top losers in the BSE HEALTHCARE Index today is BIOCON (down 5.0%).

AJANTA PHARMA (up 6.8%) and DR. LAL PATHLABS LTD (up 2.9%) are among the top gainers today.

Over the last one year, BIOCON has moved down from Rs 668 to Rs 595, registering a loss of Rs 73 (down 10.9%)..

The BSE HEALTHCARE has moved up from 14,154 to 14,413, registering a gain of 259 points (up 1.8%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were SUVEN LIFESCIENCES (up 47.5%), DIVIS LABORATORIES (up 43.3%) and DR. REDDYS LAB (up 39.2%).

What About the Benchmark Indices?

The BSE Sensex is at 39,190 . The top gainers among the BSE Sensex stocks today are YES BANK (up 3.1%). The most traded stocks in the BSE Sensex are YES BANK and ITC.

In the meantime, NSE Nifty is at 11,789 (down 0.1%). YES BANK (up 3.1%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,160 to 39,190, registering a gain of 4,030 points (up 11.0%).

BIOCON Financial Update...

BIOCON net profit down at Rs 705 million for the quarter ended March 2019, compared to a loss of Rs 2 billion a year ago. Net Sales declined 50.4% to Rs 7.6 billion during the period as against Rs 15.4 billion in January-March 2018.

For the year ended March 2018, BIOCON reported 35.7% decrease in net profit to Rs 4.3 billion compared to net profit of Rs 6.7 billion during FY17.

Revenue of the company grew 5.3% to Rs 41 billion during FY18.

The current Price to earnings ratio of BIOCON , based on rolling 12 month earnings, stands at 41.3x.